Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 2Phase 2 1Phase 1/2 1

Status

Recruiting 589Active not recruiting 179Completed 157Not yet recruiting 130Terminated 96Suspended 13Enrolling by invitation 13Withdrawn 7Unknown 1No longer available 1Available 1

Sponsor Class

INDUSTRY 5OTHER 1NIH 1

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 51Genitourinary 44Breast 40Lymphoid 34Thoracic 25Head & Neck 24CNS 24Other hematologic neoplasm 20Tumor-Agnostic 18Gynecologic 14Dermatologic 11Plasma cell 8Sarcoma 7Other solid neoplasm 7Classical hematology 5Myeloid 4Other 1

Conditions

Solid Tumor 2Advanced Solid Tumors 2Solid Tumors 1Retinoblastoma 1Mesothelioma, Malignant 1Mesothelioma 1

Interventions

tislelizumab 1atezolizumab 1Etoposide 1Carboplatin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Withdrawn × Other solid neoplasm × 1 year × Clear all
NCT07152236 2026-05-28

Clinical Study on the Safety and Efficacy of B7H3 CAR T Cells in Patients With B7H3 Positive Solid Tumors

Guangzhou Bio-gene Technology Co., Ltd

Phase NA Withdrawn
Other solid neoplasm

Solid Tumors

NCT06145802 2026-04-29

Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (Gynecological Tumors)

Grit Biotechnology

Phase NA Withdrawn
Other solid neoplasm

Solid Tumor

NCT05982522 2026-03-27

IN10018 Combination Therapy in Previously-treated Solid Tumors

InxMed (Shanghai) Co., Ltd.

Phase 1/2 Withdrawn
Other solid neoplasm

Solid Tumor

NCT06654050 2026-03-17

Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma

National Institutes of Health Clinical Center (CC)

Phase 2 Withdrawn
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT04344652 2025-09-26

Photoscreening for Retinoblastoma

Phoenix Children's Hospital

Phase NA Withdrawn
Other solid neoplasm

Retinoblastoma

NCT06235541 2025-07-17

A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors

Genome & Company

Phase 1 Withdrawn
Other solid neoplasm

Advanced Solid Tumors

NCT06719973 2025-06-17

Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)

EMD Serono

Phase 1 Withdrawn
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡